Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of ‘willingness to pay’ (WTP). Read on to explore 4 factors that impact WTP and compare 5 methodologies for price testing with payers.
Louise Maddison (Senior Consultant – Global Market Access, Mtech Access) explores the evolving market access landscape for AI-enabled Medtech, with a particular focus on the key European markets of France, Germany and the UK.
Louise Maddison joined Mtech Access as a Senior Consultant in our Market Access Team, earlier this year. Here, she talks about her career journey and her experiences since joining Mtech Access.
Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US and highlight important considerations for companies seeking to infiltrate this key market.
We delve into ICER’s influence on drug pricing and access in the US. We also explore the importance of maximising engagement with ICER for favourable pricing and access outcomes.
We bring together specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024-25. Jump in, as our experts give their hot-take on each trend, sharing their perspectives on what’s happening in these areas.